Showing results (281-290 of 344) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple MyelomaAntonio Palumbo, Francesca Gay, Federica Cavallo, et al.
European Journal of Haematology|February 29, 2020
Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world studyEmilio Iannitto, Alessandra Romano, Potito Rosario Scalzulli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2013
Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemiaMarta Lionetti, Pellegrino Musto, Maria Teresa Di Martino, et al.
Blood|February 2, 2008
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantageMarco Ladetto, Federica De Marco, Fabio Benedetti, et al.
Blood|July 21, 2010
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA GroupFrancesco Lo-Coco, Giuseppe Avvisati, Marco Vignetti, et al.
Blood|August 13, 2011
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomideAlessandra Larocca, Federica Cavallo, Sara Bringhen, et al.
Annals of Hematology|May 28, 2024
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experienceGiuseppe Mele, Daniele Derudas, Concetta Conticello, et al.
Blood|March 14, 2007
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemiaChiara Gregorj, Maria R Ricciardi, Maria T Petrucci, et al.
Genes, Chromosomes & Cancer|May 13, 2011
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemiaMichele Dal Bo, Francesca Maria Rossi, Davide Rossi, et al.
BMC Medical Genomics|May 1, 2009
The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastomaCinzia Di Pietro, Marco Ragusa, Davide Barbagallo, et al.
Pageof 35